The feasibility study for lung cancer screening by novel urinary biomarker using protein fragments: a cross-sectional study - The feasibility study for lung cancer screening by novel urinary biomarker using protein fragments: a cross-sectional study

niversity of Miyazaki0 sites200 target enrollmentJune 12, 2019

Overview

No summary available.

Registry

who.int

Start Date

June 12, 2019

End Date

December 31, 2021

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

niversity of Miyazaki

•1\)Patients who have multiple nodular shadows(more than or equal to 0\.5cm) and/or multiple mass shadows clinicaly suspected tumor metastasis and/or pleural effusion by high resolution CT within 3 months. 2\)Patients who have proteinuria, positive urine sugar or urine occult blood in urinalysis (more than or equal to 2\+). 3\)Patients who have renal dysfunction (Serum levels of creatinine \> 2\.0 mg/dl). 4\)Patients who have alcohol or drug dependence or who are suspected to have alcohol or drug dependence. 5\)Patients who is pregnant or who is suspected to be pregnant. 6\)Patients who was enrolled another clinical trial and was prescribed a study drug within one month. 7\)Patients whose attending physicians consider to be inappropriate for this study.